Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period (36 Months)	STARTED	Leuprolide Acetate 3M Depot 11.25 mg	34
Treatment Period (36 Months)	STARTED	Leuprolide Acetate 3M Depot 30 mg	38
Treatment Period (36 Months)	COMPLETED	Leuprolide Acetate 3M Depot 11.25 mg	11
Treatment Period (36 Months)	COMPLETED	Leuprolide Acetate 3M Depot 30 mg	13
Treatment Period (36 Months)	NOT COMPLETED	Leuprolide Acetate 3M Depot 11.25 mg	23
Treatment Period (36 Months)	NOT COMPLETED	Leuprolide Acetate 3M Depot 30 mg	25
Safety Follow-up Period (12 Weeks)	STARTED	Leuprolide Acetate 3M Depot 11.25 mg	28
Safety Follow-up Period (12 Weeks)	STARTED	Leuprolide Acetate 3M Depot 30 mg	26
Safety Follow-up Period (12 Weeks)	COMPLETED	Leuprolide Acetate 3M Depot 11.25 mg	28
Safety Follow-up Period (12 Weeks)	COMPLETED	Leuprolide Acetate 3M Depot 30 mg	25
Safety Follow-up Period (12 Weeks)	NOT COMPLETED	Leuprolide Acetate 3M Depot 11.25 mg	0
Safety Follow-up Period (12 Weeks)	NOT COMPLETED	Leuprolide Acetate 3M Depot 30 mg	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00667446/flow